Natco Pharma today reported a 23.91% increase in its consolidated net profit at Rs 17 crore for the quarter ended December 31, 2011.
The company had posted a net profit of Rs 13.72 crore in the same period of the last financial year, Natco Pharma said in a filing to the Bombay Stock Exchange (BSE).
The consolidated total income during the third quarter also went up by 22.89% to Rs 145.43 crore from Rs 118.34 crore in the year-ago period, it added.
The board of directors also declared an interim dividend of Rs 3 per equity share of Rs 10 each for 2011-2012.
The shares of the company today closed 1.04% lower at Rs 272.20 apiece on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app